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Methicillin-resistant Staphylococcus pseudintermedius (MRSP) is of worldwide concern in veterinary 
medicine. The identification of resistant strains is necessary for proper treatment and the prevention of its 
propagation among animals. This study aimed to identify S. pseudintermedius isolated from canine pyoderma 
and evaluate their resistance profiles. Lesions from 25 dogs with pyoderma were sampled. Bacterial isolates 
were subjected to phenotypic and genotypic analysis for identification of the causative agent. S. 
pseudintermedius isolates were subjected to SmaI macrorestriction analysis and PFGE for genetic grouping, 
and PCR to identify the presence of the mecA gene. Their resistance profiles against 12 antimicrobials were 
also assessed. According to the microbiological analysis, 70 of the 75 isolates obtained were S. 
pseudintermedius. The isolates presented PFGE patterns, with similarity varying between 84.6 and 100%, and 
were grouped into 19 clusters. Despite a high frequency of mecA-positive isolates (66 out 70), only 12 
presented resistances to oxacillin. Multi-resistance was identified in 29 isolates. The high frequency of MRSP 
isolated in this study highlights the relevance of identifying resistant strains to lead proper clinical treatment.  
 




Staphylococcus pseudintermedius meticilina-resistente (MRSP) é de preocupação mundial na medicina 
veterinária. A identificação de cepas resistentes é necessária a um tratamento adequado e à prevenção da sua 
propagação entre os animais. O objetivo do estudo foi identificar S. pseudintermedius isolados de piodermite 
canina e avaliar o perfil de resistência. Foram coletadas amostras de lesões de 25 cães com piodermite. Os 
isolados bacterianos foram submetidos a análises fenotípicas e genotípicas para identificação do agente 
causador. Isolados de S. pseudintermedius foram submetidos à análise de macrorrestrição por SmaI e PFGE 
para agrupamento genético e à PCR para identificar a presença do gene mecA. Seu perfil de resistência 
contra 12 antimicrobianos também foi avaliado. De acordo com a análise microbiológica, 70 dos 75 isolados 
obtidos foram identificados como S. pseudintermedius. Os isolados apresentaram padrões de PFGE com 
similaridade variando entre 84.6 e 100% e foram agrupados em 19 grupos genéticos. Apesar da frequência 
alta de isolados mecA positivos (66 em 70), apenas 12 apresentaram resistência à oxacilina. Multirresistência 
foi identificada em 29 isolados. A alta frequência de MRSP isolados neste estudo destaca a relevância de se 
identificarem cepas resistentes para se conduzir um tratamento clínico adequado.  
 





Staphylococcus pseudintermedius is considered 
the most frequently isolated agent from canine 
pyoderma (Devriese et al., 2009), being the most 
common reason for antimicrobial use in dogs. 
The Staphylococcus genus is characterized  
by its easy development of antimicrobial 
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resistance (Guardabassi et al., 2004; Weese  
and van Duijkeren, 2010). Methicillin-resistant 
staphylococci (MRS) are resistant to 
cephalosporins, amoxicillin/clavulanic acid, 
imipenem, ampicillin/sulbactam and other  
β-lactam antimicrobials. For proper 
characterization, the acronym MRS is commonly 
used, although oxacillin is currently the agent of 
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Methicillin-resistant S. aureus (MRSA)  
and methicillin-resistant S. pseudintermedius 
(MRSP) are of great concern in veterinary 
medicine and public health (Weese and van 
Duijkeren, 2010). In dogs with pyoderma, the 
occurrence of MRSP may vary between 0 and 
66% (Medleau et al., 1986; Kania et al., 2004; 
Sasaki et al., 2007; Griffeth et al., 2008; 
Kawakami et al., 2010). 
 
The most reliable test to identify MRS is a PCR 
protocol targeting the mecA gene, which encodes 
the supplemental penicillin-binding protein, 
PBP2a (Schissler et al., 2009). This protein is 
expressed either homogeneously, which is easily 
detected with standard testing methods, or 
heterogeneously, which is more difficult to 
detect with those methods, since only a fraction 
of the population expresses the resistance 
phenotype (Bemis et al., 2006). This study aimed 
to characterize S. pseudintermedius isolates from 
canine pyoderma by phenotypic and genotypic 
methods, and evaluate their resistance profiles to 
antimicrobials and the presence of the mecA 
gene. 
 
MATERIAL AND METHODS 
 
Twenty-five dogs from different households 
attended at the dermatology sector of a 
Veterinary Hospital located in Minas Gerais 
State, Brazil, were selected for this study. The 
inclusion criteria were clinical signs of either 
superficial or deep pyoderma, associated with 
positive skin cytology for bacterial organisms. 
None of the animals had received topical or 
systemic antimicrobial treatment for at least three 
weeks prior to sampling. Owner consent was 
obtained before animal inclusion in the study. 
This work was approved by the Bioethics 
Committee and/or Biosecurity, protocol number 
11/2011. Clinical samples were collected from 
typical lesions, such as pustules, epidermal 
colarettes, draining tracts or under crusts, using a 
sterile swab. The sampling was performed 
carefully to avoid contamination with non-
pathogenic microorganisms, as previously 
described by Ihrke (1987) and White, et al. 
(2005). Information about previous antimicrobial 
use was obtained from dermatologic medical 
records. 
 
The swabs obtained were immersed in 1mL of 
0.85% NaCl (w/v) and stirred vigorously. Then, 
200µL aliquots were streaked with a sterile swab 
on sheep blood agar (5% v/v) and MacConkey 
Agar (Oxoid Ltd., England) simultaneously and 
incubated at 37°C for 24h. Three isolated 
colonies of the samples obtained from each 
animal were transferred to brain heart infusion 
(BHI, Oxoid, England) broth, incubated at 37°C 
for 24h, and then aliquoted before being stored in 
20% glycerol (v/v) at -80°C. As guidance, the 
dogs were identified with numbers 01 to 25, and 
their respective isolates using the animal number 
followed by 1, 2 and 3. 
 
After sample collection all isolates were 
subjected to phenotypic and biochemical tests 
(Gram staining, catalase, oxidase and coagulase 
production, haemolysis, maltose and mannitol 
fermentation and Baird-Parker agar growth) for a 
preliminary identification. The isolates were also 
subjected to phenotypic identification using API 
Staph and the Apiweb V4.1 database 
(BioMérieux SA, France). 
 
DNA was extracted from the isolates using the 
Wizard Genomic DNA Purification Kit 
(Promega Corp., USA). The obtained DNA was 
subjected to PCR-RFLP for SIG identification, 
using the Bannoehr et al. (2009) method. PCR 
reactions targeting the pta gene were prepared at 
a final volume of 50µL, composed of 2µL of 
DNA, 25µL of the GoTaq Green Master Mix 
(Promega Corp., USA), 1µL of each  
primer (F1: AAAGACAAACTTTCAGGTAA 
and R1:GCATAAACAAGCATTGTACCG, 
both at 10pmol/µL), and 21µL of PCR ultra-pure 
water (Promega Corp., USA). The PCR 
conditions were 95 °C for 2min, 30 cycles of 
95°C for 1min, 53°C for 1min, 72°C for 1 min, 
and 72°C for 7min. Twenty-five-microliter 
aliquots of amplification products were added to 
5U of the MboI macrorestriction enzyme (New 
England Biolabs Inc., USA) and 5µL of its 
digestion buffer, before being incubated at 37°C 
for 2h. Digested PCR products were subjected to 
electrophoresis on 2.0% (w/v) agarose gels in 
0.5Tris/Borate/EDTA (TBE) buffer, stained 
with GelRed (Biotium Inc., USA), and visualized 
in a transilluminator. S. pseudintermedius MRSP 
3279 and S. aureus USA 100 were used as 
positive and negative controls, respectively. 
 
Isolates that presented typical phenotypic 
characteristics and PCR-RFLP products with  
213 and 107bp were identified as S. 
pseudintermedius. 
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Isolates identified as S. pseudintermedius were 
subjected to macrorestriction by SmaI (Promega 
Corp., USA) and PFGE to determine their 
genetic relationships (Hauschild and Wójcik, 
2007; Fazakerley et al., 2010). Agarose plugs 
were prepared as described by Mulvey, et al. 
(2001) and the electrophoresis conditions were 1-
10s pulse time, 6V/cm, 120° angle, 14°C for 22h, 
using the Pulse Marker™ 50-1,000 kb as the 
molecular weight marker (Sigma-Aldrich, USA). 
Gels were stained with GelRed™ (Biotium Inc., 
USA) and visualized in a transilluminator under 
UV light. The obtained bands were analyzed 
using BioNumerics software v. 6.6.4 (Applied 
Maths, Belgium). A dendrogram was obtained 
with the average linkage method (UGPMA), 
using the Dice coefficient with 5% tolerance. 
Clusters were defined considering 95% of 
similarity. 
 
The antimicrobial resistance assay was 
performed according to the CLSI (2008) method. 
Isolates identified as S. pseudintermedius were 
streaked on BHI agar (Oxoid Ltd., England) 
plates and incubated at 37°C for 24h. Isolated 
colonies were transferred to BHI broth (Oxoid 
Ltd., England) and incubated at 37°C. The 
turbidity of active growing broth cultures was 
adjusted to the MacFarland turbity standard of 
0.5. The obtained cultures were streaked on 
Mueller-Hinton (Oxoid Ltd., England) plates, 
and the disks containing antimicrobials were 
placed on each plate at equivalent distances 
(maximum five per plate). Each assay was 
performed in duplicate, and then incubated at 
37°C for 24h. Plates containing oxacillin were 
incubated at 35°C for 24h. After incubation, 
inhibition zones were recorded using a caliper 
graph (CLSI, 2008). The following 
antimicrobials were tested: amoxicillin (10µg), 
amoxicillin + clavulanic acid (30µg), 
azithromycin (15µg), cefaclor (30µg), cephalexin 
(30µg), ciprofloxacin (5µg), clindamycin (2µg), 
doxycycline (30µg), enrofloxacin (30µg), 
imipenem (10µg), oxacillin (1µg), and 
sulfadiazine + trimethoprim (25µg) (Cefar 
Diagnostics Ltda, Brazil). The inhibition zone 
diameters were evaluated using the CLSI method 
(CLSI, 2008) and the manufacturer’s 
recommendations (Cefar Diagnostics Ltda, 
Brazil). Bacterial inhibition zones were measured 
using the interpretive criterion of ≤17mm for 
oxacillin resistance, as proposed by Schissler, et 
al. (2009). S. aureus ATCC 29213 was used as a 
control for antimicrobial susceptibility as 
recommended by Olsson-Liljequist, et al. (2002). 
 
DNA from all S. pseudintermedius isolates was 
subjected to PCR to identify the presence of the 
mecA gene, according to Bannoehr, et al. (2007). 
PCR reactions were performed in a final volume 
of 25µl containing 2µl of DNA, 12.5µl of the 
GoTaq green Master Mix (Promega Corp., USA), 
8.5µl of nuclease-free water, and 1µl of each 
primer (F1: GTAGAAATGACTGAACGTCCGATAA 
and R1: CCAATTCCACATTGTTTCGGTCTAA, 
both at 10pmol/µL). PCR conditions consisted of 
an initial denaturation for 5min at 95°C, followed 
by 30 cycles of denaturation for 45s at 95°C, 
annealing for 45s at 52°C, extension for 1min at 
72°C and a final extension for 5min at 72°C. 
Five-microliter aliquots of amplification products 
were electrophoresed on 2.0% (w/v) agarose gels 
in 0.5 TBE buffer, stained with GelRed 
(Biotium Inc., USA), and visualized in a 
transilluminator. S. pseudintermedius MRSP 
3279 and S. aureus USA 100 were used as 
positive and negative controls, respectively. 
Isolates that presented a PCR product with 310 




According to the medical records of the dogs that 
were included in the study, nine individuals had 
previous antimicrobial use and cephalexin was 
the most commonly used (seven dogs). The 
previous antimicrobial use of the other 16 
animals was not determined. 
 
Considering the microbiological analysis, 70 of 
the 75 isolates obtained from 25 animals were 
identified as S. pseudintermedius and the other 
five isolates were classified as Staphylococcus 
sp. (isolates number 3.1, 6.1, 6.2, 6.3 and 16.2). 
These five isolates were not included in the 
present study. 
 
A total of 67 isolates presented SmaI 
macrorestriction patterns (except isolates 7.2, 7.3 
and 11.2), with similarity among them varying 
between 84.6 and 100% (Figure 1). The isolates 
were clustered in two major groups, one 
composed by 12 isolates (sharing similarity 
indexes between 85.6 to 100%) and the other by 
55 isolates (similarity indexes between 86.4 and 
100%). In addition, the isolates were grouped 
considering a similarity index of 85%, resulting 
in a total of 19 clusters (Figure 1). 
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Figure 1. Schematic representation of the obtained PFGE profiles after DNA macrorestriction (SmaI) of 
Staphylococcus pseudintermedius isolates obtained from canine pyoderma. Similarities between the 
identified PFGE profiles were estimated using the Dice coefficient (5% tolerance); 2 major groups  
(1 and 2) were established, and 19 clusters (I to XIX) were defined considering 95% similarity. 
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Based on PCR analysis for mecA, 66 out of 70 
presented positive results; only isolates 08.1, 
08.2, and 23.3 from cluster VII and isolate 13.2 
from cluster IX were negative (Figure 1). In 
addition, all animals included in this study 
showed at least one MRSP strain. 
 
Results for antimicrobial susceptibility and 
resistance patterns of the isolates within the two 
major groups obtained by PFGE are presented in 
Table 1 and 2, respectively. None of the tested 
isolates displayed resistance to imipenem and 12 
presented resistance to oxacillin. Amoxicillin 
was the antimicrobial with the highest number of 
resistant isolates (47/67) (Table 1). Three isolates 
from PFGE group 1 combined with 8 isolates 
from PFGE group 2 showed multi-resistance to 
at least 8 out of 12 antimicrobials tested; thus, 29 
out of 67 isolates (43.3%) were identified as 
multi-resistant (Table 2). 
 
Table 1. Individual susceptibility to antimicrobials by Staphylococcus pseudintermedius isolates obtained 
from canine pyoderma, grouped in two groups with 85% similarity by SmaI macrorestriction profiles 
(Figure 1) 
Antimicrobial 
Group 1  
(n = 12 isolates) 
Group 2  
(n = 55 isolates) 
R I S R I S 
Oxacillin 3  0  9  8  0  47  
Amoxicillin 4  0  8  43  0  12  
Amoxicillin and Clavulanic acid 2  0  10  6  0  49  
Clindamycin 3  1  8  16  0  39  
Azithromycin 4  0  8  16  0  39  
Sulfadiazine and trimethoprim 4  0  8  24  0  31  
Cephalexin 3  0  9  4  0  51  
Enrofloxacin 3  1  8  13  0  42  
Imipenem 0  0  12  0  0  55  
Doxycycline 0  0  12  11  8  36  
Cefaclor 3  0  9  6  1  48  
Ciprofloxacin 3  0  9  13  0  42  
R: resistant, I: intermediary, S: sensitive. * Isolates that did not present SmaI digestion pattern, one strain presented 
simultaneous resistance to Oxacillin, Amoxicillin, Amoxicillin and Clavulanic acid. 
 
Table 2. Multiple resistance patterns related to distinct combinations of antimicrobials of Staphylococcus 
pseudintermedius isolates obtained from canine pyoderma, according to PGFE SmaI macrorestriction 
profiles (85% similarity, Figure 1) 
Antimicrobial resistance pattern*    PGFE Group 1 (n) PGFE Group 2 (n)
Only AMO   0 18 
Only DOX   0 2 
Only SUT   0 1 
AMC AMO         0 1 
AMO OXA         0 1 
AMO SUT         0 3 
AMO AZI  SUT        1 0 
AMO DOX SUT        0 1 
AMO AZI CLI SUT       0 6 
AMO CIP ENO SUT        0 1 
AMO CIP DOX ENO SUT      0 2 
AMO AZI CLI CIP DOX ENO SUT    0 2 
AMC AMO AZI CIP CLI DOX ENO SUT   0 1 
AMC AMO AZI CFE CIP CLI ENO OXA SUT  0 1 
AMO AZI CFC CFE CIP CLI ENO OXA SUT  1 0 
AMO AZI CFC CIP CLI DOX ENO OXA SUT  0 3 
AMC AMO AZI CFC CFE CIP CLI ENO OXA SUT 2 3 
**OXA: Oxacillin; AMO: Amoxicillin; AMC: Amoxicillin and Clavulanic acid; CLI: Clindamycin; AZI: 
Azithromycin; SUT: Sulfadiazine and trimethoprim; CFE: Cephalexin; ENO: Enrofloxacin; DOX: Doxycycline; 
CFC: Cefaclor; CIP: Ciprofloxacin. Isolates that did not present SmaI digestion pattern, one strain presented 
simultaneous resistance to Oxacillin, Amoxicillin, Amoxicillin and Clavulanic acid, Cephalexin and Doxycycline. 
Bourguignon et al. 
304  Arq. Bras. Med. Vet. Zootec., v.68, n.2, p.299-306, 2016 
DISCUSSION 
 
As expected, 93.3% (70/75) of the isolates from 
25 dogs with superficial and deep pyoderma 
were S. pseudintermedius, since it is the most 
common agent isolated from canine pyoderma 
(Devriese et al., 2009). All three isolates from 
animal 6 were identified as S. pseudintermedius 
by phenotypic methods but could not be 
identified using PCR-RFLP. Two isolates (3.1 
and 16.2) were coagulase negative, probably 
being contaminants in the lesions. 
 
Considering SmaI macrorestriction and PFGE 
(Fig. 1), most of the isolates from the same 
animal presented a DNA digestion pattern with 
100% similarity, with some exceptions: isolate 
12.3 presented 96.5% similarity with 12.1 and 
12.2, and isolate 01.1 presented 91.7% similarity 
with 01.2 and 01.3. Another study that evaluated 
isolates from lesions of atopic dermatitis in dogs 
also found that isolates from the same animal 
were often related or even identical based on 
PFGE (Fazakerley et al., 2010). Two different 
animals (15 and 23) shared the same strain 
(100% similarity), even though they came from 
different households with no apparent contact 
between them. 
 
The antimicrobials used in this study were 
selected because of their wide use in small 
animal medicine, with the exception of 
imipenem, which, despite being an injectable β-
lactam with little use in veterinary medicine, was 
selected due to its high antibacterial activity 
(Rees, 1999). In this study, all isolates were 
susceptible to imipenem, even those resistant to 
oxacillin, confirming its antimicrobial activity 
(Tab. 1). Ruscher, et al. (2009) obtained  
similar sensitivity results, demonstrating  
the effectiveness of imipenem over S. 
pseudintermedius. The high prevalence of 
acquired resistance has limited the role of non-
potentiated amoxicillin in small animal medicine 
(Ihrke, 1987). Amoxicillin presented the highest 
resistance index among the isolates of this study 
(Tab. 1), indicating that this antimicrobial should 
be avoided when treating S. pseudintermedius 
infections. Cephalexin is considered the first 
choice in the treatment of pyoderma because it is 
safe and effective (Toma et al., 2008). This 
antimicrobial was used in seven out of nine 
animals that had been previously treated with 
antimicrobials. Nevertheless, it exhibited the 
second lowest resistance index in this study 
(11.4%, Tab. 1). Only one animal previously 
treated with cephalexin showed resistant isolates 
to this antimicrobial drug.  
 
In a previous study, Loeffler, et al. (2007) 
presented 12 multi-resistant isolates of S. 
pseudintermedius obtained from skin and ear 
infections with six different resistance profiles, 
which were resistant to at least 10 of the 
antimicrobials tested. In the present study, 50 
isolates were shown to be resistant to at least one 
antimicrobial, 15 of these were resistant to five 
or more antimicrobials (Table 2). Although only 
4 (33.3%) isolates belonging to PFGE group 1 
showed resistance to the antimicrobials tested, 3 
of these isolates were resistant to 9 or more 
antimicrobials (Table 2). Considering PFGE 
group 2, 20 out of 55 isolates (83.7%) were 
resistant to more than 3 antimicrobials, and 8 of 
them were resistant against nine or more 
antimicrobials (Table 2). Resistant isolates 
presented highly diverse resistance profiles, 
which may restrict the range of antimicrobial 
agents to be used in the treatment  
of S. pseudintermedius infections. Resistance to 
oxacillin has been described to be frequently 
associated with resistance to other groups of 
antibiotics such as macrolides, lincosamides, 
aminoglycosides, fluoroquinolones, and 
sulphonamides (Bond and Loeffler, 2012), and in 
the present study this association was observed 
(Table 2). 
 
Even when using a more rigorous interpretation 
criteria for the resistance to oxacillin (≤17mm 
inhibition zone) (Schissler et al., 2009), the 
obtained results demonstrated a large difference 
between the disk diffusion test (17.1%) and the 
detection of the mecA gene (94.3%). The 
discrepancy between the presence of mecA and 
the absence of corresponding oxacillin resistance 
has been previously noted in other studies 
(Bemis et al., 2006; Schissler et al., 2009; Feng 
et al., 2012). The presence of mecA positive S. 
pseudintermedius and S. aureus isolates that 
were susceptible to oxacillin was previously 
described (Forbes et al., 2008; Feng et al., 2012). 
Our findings suggest that the MRSP isolates in 
the present study are probably not expressing the 
resistance gene in vitro and studies that monitor 
the antimicrobial treatment of the animals with 
these strains would be necessary to elucidate the 
behavior of the bacteria in vivo.  
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Isolates that presented identical SmaI 
macrorestriction profiles (100% similarity) 
tended to display the same antimicrobial 
resistance profile and presence of mecA. Only the 
isolates 08.1, 08.2, 23.3 and 14.2 were mecA 
negative when other isolates that shared identical 
SmaI macrorestriction profiles were mecA 
positive. These results indicate that resistance 
patterns may be independent of genotypic 
clustering, as previously described by Hartmann, 
et al. (2005). 
 
The frequency of MRSP detected in the present 
study (94.3%) was much higher than those 
observed in similar studies (Medleau et al., 1986; 
Kania et al., 2004; Sasaki et al., 2007; Griffeth et 
al., 2008; Kawakami et al., 2010), which leads to 
an important concern in Veterinary Medicine in 
Brazil. Kawakami, et al. (2010) also found a 
high percentage of MRSP isolates (66.5%) 
derived from dogs with pyoderma through the 
investigation of the mecA gene. Other studies 
evaluated isolates from healthy skin revealing 
smaller percentages (Hartmann et al., 2005; 
Fazakerley et al., 2010; Onuma et al., 2012), 
which may explain the differences in our results 
that evaluated isolates from clinical lesions 
(Table 1). 
 
Further studies are necessary to monitor the 
outcome of antimicrobial therapy over a 
prolonged time to evaluate recurrences of canine 
pyoderma and to compare in vitro antimicrobial 
susceptibility with in vivo results. The results of 
this study indicate the importance of conducting 
a culture and sensitivity test to determine the best 
treatment and prevent the emergence of multi-
resistant strains. It also highlights the fact that 
molecular tools are probably needed for an 




The present study demonstrates the genetic 
variability of the S. pseudintermedius isolates 
from canine pyoderma through SmaI 
macrorestriction and PFGE analysis and the 
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